ZIM Laboratories Q3 Results
- BSE: 541400
- NSE: ZIMLAB
- ISIN: INE518E01015
- Sector: Biotechnology & Drugs
BSE
99.49
-0.18 (-0.18%)
-0.18 (-0.18%)Volume1.15 K
Updated: Fri 15 May, 2026 | 15:28:57
NSE
99.60-0.41 (-0.41%)
-0.41 (-0.41%)Volume41.58 K
Updated: Fri 15 May, 2026 | 15:29:18
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
- Total Income₹108.66 Cr.(12.80%)
- Operating Profit₹7.77 Cr.(16.35%)
- Profit After Tax₹4.40 Cr.(9.92%)
- Operating Margin7.15%(3.15%)
Note: Comparison is on YoY basis
Quarterly - ZIM Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 100.88 | 87.61 | 14.72% | 88.69 | 12.53% |
| Depreciation/ Amortization | 5.03 | 5.00 | 1.02% | 3.94 | 3.09% |
| Operating Income | 7.77 | 4.53 | 906.26% | 7.60 | 16.35% |
| Net Income | 4.40 | 2.38 | 0.00% | 4.78 | 9.92% |
| Other Operating Expenses Total | 31.68 | 25.05 | 17.35% | 27.37 | 9.09% |
| Net Income Before Taxes | 6.05 | 2.96 | 0.00% | 7.01 | 6.02% |
| Total Revenue | 108.66 | 92.14 | 22.49% | 96.29 | 12.80% |
| Selling/ General/ Admin Expenses Total | 15.58 | 15.45 | -4.54% | 13.17 | 7.63% |
| Diluted Normalized EPS | 0.90 | 0.49 | 0.00% | 0.98 | 9.76% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.